GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (LTS:0N70) » Definitions » Ending Cash Position

Biotest AG (LTS:0N70) Ending Cash Position : €41.8 Mil (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Biotest AG Ending Cash Position?

Biotest AG's Ending Cash Position for the quarter that ended in Mar. 2025 was €41.8 Mil.

Biotest AG's quarterly Ending Cash Position increased from Sep. 2024 (€24.7 Mil) to Dec. 2024 (€107.8 Mil) but then declined from Dec. 2024 (€107.8 Mil) to Mar. 2025 (€41.8 Mil).

Biotest AG's annual Ending Cash Position declined from Dec. 2022 (€116.6 Mil) to Dec. 2023 (€108.1 Mil) and declined from Dec. 2023 (€108.1 Mil) to Dec. 2024 (€107.8 Mil).

Biotest AG Ending Cash Position Historical Data

The historical data trend for Biotest AG's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Ending Cash Position Chart

Biotest AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.30 104.40 116.60 108.10 107.80

Biotest AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 84.80 66.30 24.70 107.80 41.80

Biotest AG Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Biotest AG's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=108.1+-0.3
=107.8

Biotest AG's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=107.8+-66
=41.8

Biotest AG Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Biotest AG's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotest AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (LTS:0N70) » Definitions » Ending Cash Position
Comparable Companies
XTER:FYB XTER:HPHA STU:T9G XTER:MDG1 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270 SMMT RPRX XKRX:196170 OCSE:GMAB INSM BMRN
Traded in Other Exchanges
BTTAY:USA BIESF:USA BIO3:Germany BIO3:Austria
Address
Landsteinerstrasse 5, PO Box 10 20 40, Dreieich, DEU, 63303
Website
https://www.biotest.com
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The company covers preclinical and clinical development of the preparations, plasma collection, production, as well as marketing and sales.

Biotest AG Headlines

No Headlines